SCANPHARM A/S: Financial statements 2024
CVR: 16279099
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
SCANPHARM A/S (CVR 16279099) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 26,903,798 and a net result of DKK 582,684 compared with DKK -4,424,691 the year before. That is an increase of 19.5% compared with the year before. Equity in the 2024 report amounted to DKK 2,082,684. The solvency ratio was 5.9%. The company had 42 employees in the financial year.
- Gross Profit
- DKK 26,903,798
- Profit/Loss
- DKK 582,684
- Equity
- DKK 2,082,684
- Total Assets
- DKK 35,068,324
- Employees
- 42
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 26.9 mio. | 583 t. | 2.1 mio. | 42 |
| 2023 | - | 22.5 mio. | -4.4 mio. | 1.5 mio. | 44 |
| 2022 | - | 17.4 mio. | -6 mio. | 1.5 mio. | 41 |
| 2021 | - | 11.3 mio. | -10.9 mio. | 1.5 mio. | 40 |
| 2020 | - | 5.1 mio. | -18.9 mio. | 1.9 mio. | 40 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
SCANPHARM A/S has published its annual report for 2023. Gross profit came to DKK 22,519,429, and the net result was DKK -4,424,691.
About SCANPHARM A/S
SCANPHARM A/S is a Danish company of the type Aktieselskab based in Birkerød, founded in 1992. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named SCANPHARM A/S AF 1992 and A/S SCANPHARM AF 1992. The management consists of Andreas Bjørn Jensen. The board consists of Janus Doré Pagh (chair), Andreas Bjørn Jensen and Hanne Bjørn Jensen. The company is owned by CHLOPETHAN A/S and Peluli Holding ApS. The company has 42 employees (2026). In 2025, the company reported a gross profit of DKK 29,716,677 and a net result of DKK 962,722 compared with DKK 582,684 the year before. Equity in the 2025 report amounted to DKK 3,045,406.